Race/ethnicity and underlying disease influences hematopoietic stem/progenitor cell mobilization response: A single center experience-Reference-Cited by-同舟云学术

Race/ethnicity and underlying disease influences hematopoietic stem/progenitor cell mobilization response: A single center experience

Published:2021-05-28 Issue:4 Volume:36 Page:634-644
ISSN:0733-2459
Container-title:Journal of Clinical Apheresis
language:en
Short-container-title:J Clin Apher

Author:

Uzoka Chukwuemeka¹,Liu Li C.²,Park Youngmin³,Lin Yuankai¹,Patel Pritesh¹,Campbell‐Lee Sally⁴,Sweiss Karen⁵,Wang Xinhe²,Tepak Elena³,Peace David¹,Saraf Santosh¹,Rondelli Damiano¹,Mahmud Nadim¹³^ORCID

Affiliation:

1. Division of Hematology/Oncology, Department of Medicine University of Illinois College of Medicine Chicago Illinois USA

2. Department of Epidemiology and Biostatistics University of Illinois at Chicago Chicago Illinois USA

3. Clinical Stem Cell Laboratory, UI Blood & Marrow Transplant Program University of Illinois Hospital and Health Sciences System Chicago Illinois USA

4. Department of Pathology University of Illinois at Chicago Chicago Illinois USA

5. Department of Pharmacy Practice College of Pharmacy, University of Illinois at Chicago Chicago Illinois USA

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jca.21914

Reference38 articles.

1. The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Diffuse Large B Cell Lymphoma: Update of the 2001 Evidence-Based Review

2. The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Follicular Lymphoma: An Evidence-Based Review

3. High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma

4. High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA

5. Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Phenotype

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cryopreserved hematopoietic stem/progenitor cells stability program-development, current status and recommendations: A brief report from the AABB-ISCT joint working group cellular therapy product stability project team;Cytotherapy;2022-05

2. Cryopreserved hematopoietic stem/progenitor cells stability program‐development, current status and recommendations: A brief report from the AABB‐ISCT joint working group cellular therapy product stability project team;Transfusion;2022-03

3. Development of a quantitative prediction model for peripheral blood stem cell collection yield in the plerixafor era;Cytotherapy;2022-01